| MIR143 |
|
microRNA 143
|
|
|
0.462 |
0.885 |
| PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
| C20orf181 |
|
chromosome 20 open reading frame 181
|
|
|
0.479 |
0.885 |
| MIR29C |
|
microRNA 29c
|
|
|
0.496 |
0.808 |
| H3P40 |
|
H3 histone pseudogene 40
|
|
|
0.506 |
0.846 |
| TMX2-CTNND1 |
|
TMX2-CTNND1 readthrough (NMD candidate)
|
|
|
0.538 |
0.769 |
| CTAA1 |
|
cataract, anterior polar 1
|
|
|
0.568 |
0.731 |
| LOH19CR1 |
|
loss of heterozygosity, 19, chromosomal region 1
|
|
|
0.569 |
0.808 |
| CECR |
|
cat eye syndrome chromosome region
|
|
|
0.599 |
0.731 |
| LOC107987479 |
|
cytochrome P450 2D6
|
|
|
0.597 |
0.769 |
| LOC110806262 |
|
solute carrier family 6 member 4 gene promoter
|
|
|
0.626 |
0.423 |
| CST12P |
|
cystatin 12, pseudogene
|
|
|
0.641 |
0.615 |
| GTS |
|
Gilles de la Tourette syndrome
|
|
|
0.682 |
0.615 |
| GULOP |
|
gulonolactone (L-) oxidase, pseudogene
|
|
|
0.805 |
0.308 |
| MACROD2 |
A1Z1Q3
|
mono-ADP ribosylhydrolase 2
|
|
0.43 |
0.686 |
0.423 |
| C5orf63 |
A6NC05
|
chromosome 5 open reading frame 63
|
|
4.5E-03 |
0.890 |
0.077 |
| HACD1 |
B0YJ81
|
3-hydroxyacyl-CoA dehydratase 1
|
|
1.3E-09 |
0.539 |
0.846 |
| TLR4 |
O00206
|
toll like receptor 4
|
|
4.6E-09 |
0.321 |
0.962 |
| AGRP |
O00253
|
agouti related neuropeptide
|
Signaling
|
7.0E-04 |
0.488 |
0.769 |
| QSOX1 |
O00391
|
quiescin sulfhydryl oxidase 1
|
Enzyme
|
2.6E-05 |
0.670 |
0.577 |
| FAAH |
O00519
|
fatty acid amide hydrolase
|
|
4.4E-11 |
0.545 |
0.692 |
| CXCR6 |
O00574
|
C-X-C motif chemokine receptor 6
|
G-protein coupled receptor
|
5.7E-05 |
0.448 |
0.885 |
| ABLIM1 |
O14639
|
actin binding LIM protein 1
|
Cellular structure
|
0.93 |
0.839 |
0.154 |
| RASGRF2 |
O14827
|
Ras protein specific guanine nucleotide releasing factor 2
|
Enzyme modulator
|
0.15 |
0.644 |
0.615 |
| RAD51B |
O15315
|
RAD51 paralog B
|
|
2.1E-15 |
0.556 |
0.769 |